1. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations. Issue 7 (July 2019) Authors: Soumerai, Jacob D; Ni, Ai; Darif, Mohamed; Londhe, Anil; Xing, Guan; Mun, Yong; Kay, Neil E; Shanafelt, Tait D; Rabe, Kari G; Byrd, John C; Chanan-Khan, Asher A; Furman, Richard R; Hillmen, Peter; Jones, Jeffrey; Seymour, John F; Sharman, Jeffrey P; Ferrante, Lucille; Mobasher, Mehrdad; Stark, Th... Journal: Lancet Issue: Volume 6:Issue 7(2019) Page Start: e366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma. Issue 1 (10th December 2021) Authors: Martin, Thomas; Krishnan, Amrita; Yong, Kwee; Weisel, Katja; Mehra, Maneesha; Nair, Sandhya; Qi, Keqin; Londhe, Anil; Diels, Joris; Crivera, Concetta; Jackson, Carolyn C.; Olyslager, Yunsi; Vogel, Martin; Schecter, Jordan M.; Banerjee, Arnob; Valluri, Satish; Usmani, Saad Z.; Berdeja, Jesus G.; J... Journal: EJHaem Issue: Volume 3:Issue 1(2022) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancer. Issue 6 (12th November 2020) Authors: Rao, Arpit; Scher, Howard I; De Porre, Peter; Yu, Margaret K; Londhe, Anil; Qi, Keqin; Morris, Michael J; Ryan, Charles Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations. (December 2021) Authors: Bazhenova, Lyudmila; Minchom, Anna; Viteri, Santiago; Bauml, Joshua M.; Ou, Sai-Hong Ignatius; Gadgeel, Shirish M.; Trigo, José Manuel; Backenroth, Daniel; Li, Tracy; Londhe, Anil; Mahadevia, Parthiv; Girard, Nicolas Journal: Lung cancer Issue: Volume 162(2021) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma. (June 2019) Authors: Martin, Peter; Goy, Andre; Ramchandren, Radhakrishnan; Ferrante, Lucille; Londhe, Anil; McGowan, Tracy; Bartlett, Nancy L Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 4(2019) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancer. Issue 6 (12th November 2020) Authors: Rao, Arpit; Scher, Howard I; De Porre, Peter; Yu, Margaret K; Londhe, Anil; Qi, Keqin; Morris, Michael J; Ryan, Charles Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancer. Issue 6 (12th November 2020) Authors: Rao, Arpit; Scher, Howard I; De Porre, Peter; Yu, Margaret K; Londhe, Anil; Qi, Keqin; Morris, Michael J; Ryan, Charles Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancer. Issue 6 (12th November 2020) Authors: Rao, Arpit; Scher, Howard I; De Porre, Peter; Yu, Margaret K; Londhe, Anil; Qi, Keqin; Morris, Michael J; Ryan, Charles Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancer. Issue 6 (12th November 2020) Authors: Rao, Arpit; Scher, Howard I; De Porre, Peter; Yu, Margaret K; Londhe, Anil; Qi, Keqin; Morris, Michael J; Ryan, Charles Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of clinical versus radiographic progression on clinical outcomes in metastatic castration-resistant prostate cancer. Issue 6 (12th November 2020) Authors: Rao, Arpit; Scher, Howard I; De Porre, Peter; Yu, Margaret K; Londhe, Anil; Qi, Keqin; Morris, Michael J; Ryan, Charles Journal: ESMO open Issue: Volume 5:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗